mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.008 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.009 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.009 |